Award
Delivery Order #SPE2DR26FDF2E
Delivery Order for XYOSTED Auto-Injector Under Strategic Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$788.85
Ceiling
$788.85
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26FDF2E
NAICS
424210
This delivery order contract was awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical sourcing and distribution company. The order pertains specifically to the procurement of XYOSTED 75 MG/0.5 ML auto-injectors, a pharmaceutical product intended for therapeutic use. This award is significant as it represents a critical fulfillment step under an existing strategic pharmaceutical supply indefinite delivery vehicle (IDV) contract, ensuring continued access to essential medications for federal supply needs. The scope of work includes the prompt delivery of the specified auto-injectors within a focused multi-day period, contributing to the overall reliability and responsiveness of the federal healthcare infrastructure. The contract follows the framework of the parent IDV contract and was awarded on a delivery order basis, implying it is part of a broader, competitively awarded agreement. The contract's performance period is concise, emphasizing timely delivery with operational coordination centered in Conshohocken, Pennsylvania.
Description
4570827945!XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML